JP2000510150A - 置換1,3―ベンゾジオキソール - Google Patents

置換1,3―ベンゾジオキソール

Info

Publication number
JP2000510150A
JP2000510150A JP09541097A JP54109797A JP2000510150A JP 2000510150 A JP2000510150 A JP 2000510150A JP 09541097 A JP09541097 A JP 09541097A JP 54109797 A JP54109797 A JP 54109797A JP 2000510150 A JP2000510150 A JP 2000510150A
Authority
JP
Japan
Prior art keywords
phenyl
chloro
hydroxy
benzo
dioxole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP09541097A
Other languages
English (en)
Japanese (ja)
Inventor
ギルバート,アダム・マシュー
グロス,ジョージ・セオドア
マラマス,マイケル・ソティリオス
スム,フク―ワー
ベンカテサン,アラナパカム・ミデュムバイ
フランシスコ,ジェラルド・デ・ラ・クルツ
Original Assignee
アメリカン・ホーム・プロダクツ・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アメリカン・ホーム・プロダクツ・コーポレイション filed Critical アメリカン・ホーム・プロダクツ・コーポレイション
Publication of JP2000510150A publication Critical patent/JP2000510150A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896Compounds having one or more Si-O-acyl linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP09541097A 1996-05-14 1997-05-09 置換1,3―ベンゾジオキソール Pending JP2000510150A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64597096A 1996-05-14 1996-05-14
US08/645,970 1996-05-14
PCT/US1997/008148 WO1997043273A1 (fr) 1996-05-14 1997-05-09 1,3-benzodioxoles substitues

Publications (1)

Publication Number Publication Date
JP2000510150A true JP2000510150A (ja) 2000-08-08

Family

ID=24591209

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09541097A Pending JP2000510150A (ja) 1996-05-14 1997-05-09 置換1,3―ベンゾジオキソール

Country Status (10)

Country Link
EP (1) EP0901484A1 (fr)
JP (1) JP2000510150A (fr)
KR (1) KR20000011001A (fr)
AU (1) AU730659B2 (fr)
BR (1) BR9708948A (fr)
CA (1) CA2254120A1 (fr)
HU (1) HUP9902088A2 (fr)
IL (1) IL126780A0 (fr)
NZ (1) NZ332713A (fr)
WO (1) WO1997043273A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3797108B1 (fr) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulateurs de l'enzyme méthyl modifiant, compositions et leur utilisation.
CA3148444A1 (fr) * 2019-07-24 2021-01-28 Constellation Pharmaceuticals, Inc. Therapies d'inhibition d'ezh2 pour le traitement des cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5482971A (en) * 1993-10-01 1996-01-09 American Cyanamid Company Beta3 -adrenergic agents and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
IL126780A0 (en) 1999-08-17
BR9708948A (pt) 1999-08-03
CA2254120A1 (fr) 1997-11-20
HUP9902088A2 (hu) 2001-04-28
WO1997043273A1 (fr) 1997-11-20
KR20000011001A (ko) 2000-02-25
AU730659B2 (en) 2001-03-08
AU3006797A (en) 1997-12-05
EP0901484A1 (fr) 1999-03-17
NZ332713A (en) 2000-07-28

Similar Documents

Publication Publication Date Title
DE69926752T2 (de) Therapeutisch wirksame biaryl-derivate
RU2174121C2 (ru) Производные пропионовой кислоты и фармацевтическая композиция на их основе
DE60216094T2 (de) Modulatoren der peroxisom-proliferator-aktivierten rezeptoren (ppar)
DE69706658T2 (de) Substituierte 4-hydroxyphenylalkansaure-derivate mit agonistischer wirkung auf ppar-gamma
HU230612B1 (hu) Kemokin receptorokat módosító hatású 3-aminopirrolidin-származékok
CN103998443A (zh) 具有β2肾上腺素能激动剂及M3毒蕈碱拮抗剂的活性的新型环己胺衍生物
DE69722258T2 (de) Neue verbindungen nutlich als neuroschützende mittel
SE447116B (sv) Nya spiro-oxazolidindioner och farmaceutiska beredningar innehallande desamma
CN1206419A (zh) 膦酸二酯衍生物
US6831080B2 (en) Cinnamide derivatives as KCNQ potassium channel modulators
DE60128239T2 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
EA031654B1 (ru) Гидроксиформамидные производные и их применение
JP2002503247A (ja) Pge2アゴニストおよびアンタゴニストとして有用なオキサゾール化合物
JP2024516633A (ja) オレキシン-2受容体アゴニスト活性を有する置換されるアミド大環状化合物
DE69317399T2 (de) Aminocycloalkanobenzodioxole als beta-3 selektive adrenergische Wirkstoffe
DE60018194T2 (de) Hydroxamsäurederivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven wirkstoff enthalten
DE69923995T2 (de) Thiazol-derivate als ppar-gamma-ligande
JP2000510150A (ja) 置換1,3―ベンゾジオキソール
US5914339A (en) Substituted 1,3-benzodioxoles
US6083975A (en) Substituted benzo[1,4]dioxines as antiobesity agents
MXPA98009384A (en) 1-3, benzodioxoles sustitui
JPH05213957A (ja) 新規なスピロピロリジンイミダゾリン誘導体および新規なアミノピロリジンカルボン酸誘導体並びに該化合物を有効成分とする鎮けい剤
JP2000509046A (ja) ヘテロサイクリック化合物群
CA2271885A1 (fr) Benzo[1,4]dioxannes substitues utilises comme agents anti-obesite
DE69714709T2 (de) Cyclische amic-säurederivate